Turning Point Therapeutics, Inc.
Macrocyclic compounds and uses thereof

Abstract:

The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.